Study on the correlation of plasma NO, ET-1 and ALT in the patients with chronic hepatitis and cirrhosis

被引:0
|
作者
Tong Qiaoxia
Zeng Linglan
机构
[1] Tongji Medical University,Department of Infectious Disease, Xiehe Hospital
关键词
chronic hepatitis B; active hepatic cirrhosis; nitric oxide; endothelin; ALT;
D O I
10.1007/BF02886989
中图分类号
学科分类号
摘要
The levels of plasma nitric oxide (NO), endothelin-1 (ET-1) and ALT in the patients with chronic hepatitis B and active cirrhosis and the correlation among them were observed and analyzed. NO3− was restored by using cadmium column assay and NO2− measured by heavy nitrogen assay. The primitive NO3− and total restored NO2− (NO3− / NO2−) in plasma of the patients with chronic hepatitis and cirrhosis. Plasma ET-1 and ALT levels were determined by using radioimmunological assay and Lai’s assay, respectively. Compared with normal control group, the plasma levels of NO2− /NO3− and ET-1 in the patients with chronic active hepatitis and active cirrhosis were significantly increased (P < 0.05 – 0.01). There was a positive correlation between NO and ALT, and ET-1 and ALT in the patients with chronic active hepatitis and active cirrhosis respectively. It was suggested that elevation of both NO and ET-1 levels were closely related with injury severity of liver function.
引用
收藏
页码:203 / 204
页数:1
相关论文
共 50 条
  • [21] Ribavirin Priming in Patients with Chronic Hepatitis C and Normal ALT: A Pilot Study
    Toex, Ulrich
    Schulte, Sigrid
    Heindl, Bjoern
    Goeser, Tobias
    Drebber, Uta
    Stelzer, Annette
    Steffen, Hans-Michael
    HEPATO-GASTROENTEROLOGY, 2008, 55 (86-87) : 1666 - 1670
  • [22] CONTRARY ALTERATIONS OF ENDOTHELIN-1 (ET-1) AND ENDOTHELIN-3 (ET-3) PLASMA-LEVELS IN CIRRHOSIS OF THE LIVER
    GERBES, AL
    GULBERG, V
    VOLLMAR, AM
    PAUMGARTNER, G
    HEPATOLOGY, 1992, 16 (04) : A82 - A82
  • [23] Reduced catabolism of endothelin-1 (ET-1) by hepatocytes - A mechanism of increased circulating and hepatic levels of ET-1 in liver cirrhosis.
    Gandhi, CR
    Kuddus, R
    FASEB JOURNAL, 1999, 13 (05): : A1029 - A1029
  • [24] High Prevalence of Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients With Normal ALT in Central Europe
    Goebel, Thomas
    Erhardt, Andreas
    Herwig, Mathias
    Poremba, Christopher
    Baldus, Stephan Ernst
    Sagir, Abdurrahman
    Heinzel-Pleines, Ulrike
    Haeussinger, Dieter
    JOURNAL OF MEDICAL VIROLOGY, 2011, 83 (06) : 968 - 973
  • [25] Correlation of HBV DNA levels in serum and liver of chronic hepatitis B patients with cirrhosis
    Lee, CZ
    Huang, GT
    Yang, PM
    Sheu, JC
    Lai, MY
    Chen, DS
    LIVER, 2002, 22 (02): : 130 - 135
  • [26] Correlation between HBV DNA level and progression to cirrhosis in patients with chronic hepatitis B
    Wang, Jiyao
    Liu, Lili
    GASTROENTEROLOGY, 2008, 134 (04) : A812 - A812
  • [27] Determination of plasma ET-1 by RIA -: Risks and limitations
    Baumgartner-Parzer, SM
    Nowotny, P
    Wagner, O
    Waldhäusl, W
    HORMONE AND METABOLIC RESEARCH, 1998, 30 (10) : 633 - 635
  • [28] Effects of ET-1 antagonism on ET-1 mediated vasoconstriction in the skin microcirculation of obese patients with atherosclerosis
    Mitchell, A
    Detmer, N
    Rushentsova, U
    Philipp, T
    INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 : S7 - S7
  • [29] Plasma endothelin-1 (ET-1) levels as marker of retinopathy (DR) in NIDDM patients
    DeMattia, G
    Vingolo, EM
    Laurenti, O
    Faldetta, C
    Barcaroli, M
    Giusti, C
    Zicari, D
    Ferri, C
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 4385 - 4385
  • [30] Increased pulmonary ET-1 release is independent, of big ET-1 and contributes to plasma ET rise in CHF during ET-receptor blockade
    Sotsch, G
    Loeffler, BM
    Yan, XW
    Kiowski, W
    CIRCULATION, 1998, 98 (17) : 134 - 134